Daxor
5 hedge funds and large institutions have $601K invested in Daxor in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 5 → 5 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.05% less ownership
Funds ownership: 1.67% → 1.62% (-0.05%)
33% less capital invested
Capital invested by funds: $893K → $601K (-$292K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$2.2K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$11 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$13.1K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$11K |
DXR Hedge Fund Activity: Q4 2022 in Review
5 of the 6,239 institutional investors tracked by Wall St. Rank reported a position in Daxor (DXR) for Q4 2022, worth a combined $601K — down 33% from $893K a quarter earlier.
Fund positioning in DXR was balanced in Q4 2022: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $2.2K. The largest seller was Tower Research Capital (TRC), cutting an estimated $13.1K.
- 5 institutional investors held Daxor (DXR) as of Q4 2022, unchanged from Q3 2022.
- Funds reported $601K of Daxor stock for Q4 2022, down 33% quarter-over-quarter.
- 1 fund opened new Daxor positions in Q4 2022 and 1 closed out, a net change of 0 holders.
- The largest Daxor buyer in Q4 2022 was Renaissance Technologies, an estimated $2.2K added.
- The largest Daxor seller in Q4 2022 was Tower Research Capital (TRC), an estimated $13.1K sold.
Based on aggregated 13F filings for Q4 2022.